搜索到 1000 条关于 61q텔레그램Dbyeonguso$❤️재테크디비문의] 的文章

心电图讲座:心电图对心肌梗死的诊断价值

2012.06.08 心电图讲座:心电图对心肌梗死的诊断价值

。当抬高的ST 段回落至等电位线时,一般代表心梗进入亚急性期阶段。1. 3 Q 波的演变更进一步的缺血则导致心肌细胞发生变性、坏死,使面向坏死区的导联出现异常Q波。所以说心肌梗死心电图中出现的异常Q 波是心肌坏死的标志,故名为坏死型Q 波。心肌坏死所致的Q 波改变略晚于T 波及ST段

2012.09.19 美式脊椎矫正手法培训班

。【食宿】:统一安排,费用自理。住宿标准40元-150元不等,餐费20元-30元/人/天。【交通路线】:深圳火车站西广场乘坐61路,人民公园站下

2020.09.09 2020 生物制品注册最新法规解析及实战(南京 10 月 16-18 日)

对质量(Q)资料的要求 3.1 CTD 药学资料要求:原液和制剂资料的撰写 3.2 

2019.09.24 2019第三届生物药工艺发展峰会圆满落幕!

了:Lifecycle Management for Biologics and ICH Q12.谷学林——副总裁,质量控制部,药明生物,分享了:Lifecycle

2018.08.28 医药电子病历信息系统与临床实验数据电子化采集的对接研讨班

15:00-15:15茶歇15:15-16:45医疗大数据与人工智能在临床科研中的机遇和挑战徐济铭 医渡云首席技术官16:45Q&A 闭幕报名

2012.09.19 SJ 国际微创美容医学暨精细整形实用技术培训班

美容整形外科学会正式会员,大韩整形外科联合会正式会员,大韩整形鄂矫正手术研究会员,眼部整形研究会会员。Q-Mad瑞兰总部临床医生专家。尹
范献良教授—儿童低通气睡眠呼吸暂停综合征

2006.07.28 范献良教授—儿童低通气睡眠呼吸暂停综合征

示腔室内径及各组瓣膜结构正常,收缩期右房内探及中等范围三尖瓣反流束,最大返流压差61mmHg,肺动脉收缩压71mmHg。呼吸36次/分,双肺呼吸音粗,无罗音,胸片示...以上治疗方式的患儿可行气管切开术,但应考虑 到它对患儿语言形成、发展及心理等各方面都有严重的不良影响。答疑实录:Q:范教授,很高兴能向你请教。我一直认为婴幼儿的

2012.09.19 首届中国PBPK模拟软件GastroPlus Workshop第二轮通知

首届中国PBPK模拟软件GastroPlus Workshop第二轮通知

北京·2012年5月16-18日

上海·2012521-23尊敬的老师,您好!生理药代动力学模型(PBPK)在药物研发与监管中得到广泛应用意味着新时代的来临!它改变了动物试验和人体实验传统研究模式流程,指导制药企业项目决策及效率提高;FDA和EMA的使用及推荐,促使国外制药企业及学术单位相关研究者都在学习及掌握PBPK的应用。为促进我国在该领域的发展,力争与全球同步,凡默谷特邀美国Simulations Plus顶尖专家来华授课,让您了解及掌握PBPK知识、获悉国外最新应用、亲授多年使用经验,授课过程将以理论与实践相结合的形式进行。GastroPlus是由美国Simulations Plus公司研发的基于机制性生理模型的药代动力学、药效动力学(PBPK/PD)模拟软件,目前在FDA和几乎所有的全球顶尖制药公司中得到广泛应用,被誉为同类软件中的“黄金标准”。为确保培训效果,限额50人/班,第一轮通知发出后,已得到广大中国用户的积极响应和踊跃报名。报名从速!为何本次GastroPlus Workshop值得您参加?1)药物研发及监管中争相应用PBPK模型的时代已经来临!2)PBPK辅助药物研究可方便指导项目决策、节约成本、缩短时间;3)FDA已广泛采用PBPK模拟来制定法规和对新药及仿制药进行审批;4)FDA及各大制药企业对全球最权威的PBPK模拟软件GastroPlus倍加青睐;5)零距离接触Simulations Plus首席科学家,并参与学习的最新应用案例;6)您可免费获得一个月的GastroPlus软件试用。本次GastroPlus Workshop将让您受益良多:1)制药企业或CRO:有利于您理解您的客户或其他Sites实验方案设计思路、下一阶段决策及实验开展、合理设计实验方案;2)学术研究:启示您开辟新的药代、药剂等研究方向,剖析药物作用机制等;3)临床药理研究:合理设计临床试验方案,不同人群PK/PD研究等;4)法规部门:协助制定新药及仿制药政策和标准。报名方法:请您填写报名回执,并通过Email的方式反馈给我们。Email: training@pharmogo.com报名截止:2012年4月20日(北京培训班)/2012年4月30日(上海培训班)联系人:周伟,电话:021-61638583-8001报名确认:1)报名确认以凡默谷收到款项或报名者提供汇款凭证为准,凡默谷可先提供发票以供报销;2)会务组在接到报名后,将email或电话通知学员培训班相关事项。温馨提醒:学员必须自带已安装好Gastroplus程序的电脑参加培训,现场不提供电脑。

GastroPlus Workshop Course Instructors List

Michael B. Bolger

Chief Scientist

Simulations Plus Inc.

Dr. Bolger is Chief Scientist at Simulations Plus, he oversees a team of scientist / programmers at Simulations Plus, Inc. (Lancaster, CA) in the development of software programs (ADMET Predictor/Modeler, MedChem Studio/Designer, GastroPlus, DDDPlus, and MembranePlus) for estimation of biopharmaceutical properties, simulations of absorption and bioavailability, automated generation QSP/AR model building, in vitro dissolution, and cell culture permeability simulation.

As a faculty member at USC School of Pharmacy, his research was supported by several NIH basic science research grants and he published over 50 peer-reviewed publications. From 1989-1991 he served as a FDA National Science Advisor. He has served as a reviewer for numerous scientific publications. He is currently Adjunct Associate Professor of Pharmaceutical Sciences at USC.

Haiying Zhou, Ph.D.

Senior Scientist II

Simulations Plus Inc.

Dr. Zhou is Senior Scientist II at Simulations Plus, she focused on the development of modeling and simulation software for quantitative understanding of the pharmacokinetics and pharmacodynamics of drug candidates (GastroPlus), in vitro dissolution of active pharmaceutical ingredients and formulation excipients under various experimental conditions (DDDPlus).

She received her M.S. degree in automation from East China University of Science and Technology (ECUST) in 2002 and her Ph.D in Biomedical Engineering from Case Western Reserve University (CWRU) in 2009. Her research interests in CWRU include multi-scale mathematical modeling of gas transport and cellular metabolism with emphasis on the metabolic regulation during different conditions, e.g. hypoxia and exercise.

John DiBella

Vice President of Marketing Simulations Plus Inc.

John DiBella is the Director – Marketing & Sales at Simulations Plus, He joined Simulations Plus in 2003 and has spent time working on the development of GastroPlus? and DDDPlus? software and consulting projects. Now, he leads the marketing & sales activities for the company while continuing to travel the world hosting training seminars.John obtained B.S. and M.S. degrees (with honors) in Biomedical Engineering from Case Western Reserve University in 2003. His graduate research was focused on computational modeling of physiological systems.

培训班详情:请下载附件参加北京培训班请点击下载:GastroPlus北京培训班第二轮通知/BeiJing GastroPlus-Intro-Workshop 2nd Notice参加北京培训班请点击下载:GastroPlus上海培训班第二轮通知/ShangHai GastroPlus-Intro-Workshop 2nd Notice

2012.09.19 首届中国PBPK模拟软件GastroPlus Workshop第二轮通知

首届中国PBPK模拟软件GastroPlus Workshop第二轮通知

北京·2012年5月16-18日

上海·2012521-23尊敬的老师,您好!生理药代动力学模型(PBPK)在药物研发与监管中得到广泛应用意味着新时代的来临!它改变了动物试验和人体实验传统研究模式流程,指导制药企业项目决策及效率提高;FDA和EMA的使用及推荐,促使国外制药企业及学术单位相关研究者都在学习及掌握PBPK的应用。为促进我国在该领域的发展,力争与全球同步,凡默谷特邀美国Simulations Plus顶尖专家来华授课,让您了解及掌握PBPK知识、获悉国外最新应用、亲授多年使用经验,授课过程将以理论与实践相结合的形式进行。GastroPlus是由美国Simulations Plus公司研发的基于机制性生理模型的药代动力学、药效动力学(PBPK/PD)模拟软件,目前在FDA和几乎所有的全球顶尖制药公司中得到广泛应用,被誉为同类软件中的“黄金标准”。为确保培训效果,限额50人/班,第一轮通知发出后,已得到广大中国用户的积极响应和踊跃报名。报名从速!为何本次GastroPlus Workshop值得您参加?1)药物研发及监管中争相应用PBPK模型的时代已经来临!2)PBPK辅助药物研究可方便指导项目决策、节约成本、缩短时间;3)FDA已广泛采用PBPK模拟来制定法规和对新药及仿制药进行审批;4)FDA及各大制药企业对全球最权威的PBPK模拟软件GastroPlus倍加青睐;5)零距离接触Simulations Plus首席科学家,并参与学习的最新应用案例;6)您可免费获得一个月的GastroPlus软件试用。本次GastroPlus Workshop将让您受益良多:1)制药企业或CRO:有利于您理解您的客户或其他Sites实验方案设计思路、下一阶段决策及实验开展、合理设计实验方案;2)学术研究:启示您开辟新的药代、药剂等研究方向,剖析药物作用机制等;3)临床药理研究:合理设计临床试验方案,不同人群PK/PD研究等;4)法规部门:协助制定新药及仿制药政策和标准。报名方法:请您填写报名回执,并通过Email的方式反馈给我们。Email: training@pharmogo.com报名截止:2012年4月20日(北京培训班)/2012年4月30日(上海培训班)联系人:周伟,电话:021-61638583-8001报名确认:1)报名确认以凡默谷收到款项或报名者提供汇款凭证为准,凡默谷可先提供发票以供报销;2)会务组在接到报名后,将email或电话通知学员培训班相关事项。温馨提醒:学员必须自带已安装好Gastroplus程序的电脑参加培训,现场不提供电脑。

GastroPlus Workshop Course Instructors List

Michael B. Bolger

Chief Scientist

Simulations Plus Inc.

Dr. Bolger is Chief Scientist at Simulations Plus, he oversees a team of scientist / programmers at Simulations Plus, Inc. (Lancaster, CA) in the development of software programs (ADMET Predictor/Modeler, MedChem Studio/Designer, GastroPlus, DDDPlus, and MembranePlus) for estimation of biopharmaceutical properties, simulations of absorption and bioavailability, automated generation QSP/AR model building, in vitro dissolution, and cell culture permeability simulation.

As a faculty member at USC School of Pharmacy, his research was supported by several NIH basic science research grants and he published over 50 peer-reviewed publications. From 1989-1991 he served as a FDA National Science Advisor. He has served as a reviewer for numerous scientific publications. He is currently Adjunct Associate Professor of Pharmaceutical Sciences at USC.

Haiying Zhou, Ph.D.

Senior Scientist II

Simulations Plus Inc.

Dr. Zhou is Senior Scientist II at Simulations Plus, she focused on the development of modeling and simulation software for quantitative understanding of the pharmacokinetics and pharmacodynamics of drug candidates (GastroPlus), in vitro dissolution of active pharmaceutical ingredients and formulation excipients under various experimental conditions (DDDPlus).

She received her M.S. degree in automation from East China University of Science and Technology (ECUST) in 2002 and her Ph.D in Biomedical Engineering from Case Western Reserve University (CWRU) in 2009. Her research interests in CWRU include multi-scale mathematical modeling of gas transport and cellular metabolism with emphasis on the metabolic regulation during different conditions, e.g. hypoxia and exercise.

John DiBella

Vice President of Marketing Simulations Plus Inc.

John DiBella is the Director – Marketing & Sales at Simulations Plus, He joined Simulations Plus in 2003 and has spent time working on the development of GastroPlus? and DDDPlus? software and consulting projects. Now, he leads the marketing & sales activities for the company while continuing to travel the world hosting training seminars.John obtained B.S. and M.S. degrees (with honors) in Biomedical Engineering from Case Western Reserve University in 2003. His graduate research was focused on computational modeling of physiological systems.

培训班详情:请下载附件参加北京培训班请点击下载:GastroPlus北京培训班第二轮通知/BeiJing GastroPlus-Intro-Workshop 2nd Notice参加北京培训班请点击下载:GastroPlus上海培训班第二轮通知/ShangHai GastroPlus-Intro-Workshop 2nd Notice

2012.09.19 北京大学医学部-艾默里医疗集团医院管理高级研修班

-10:30“Evaluation and Q&A session”10:30
合理使用抗生素可降低开放性骨折的感染风险

2014.10.28 合理使用抗生素可降低开放性骨折的感染风险

程度不同,选择不同的抗生素开放伤级别推荐抗生素抗生素过敏的替代方案I或II级指南策略:头孢唑啉 1-2g首剂,然后1g IV q8h,持续48小时;早先方案:相同克林霉素900mg IV q8h,持续48小时早先方案:万古霉素 1g IV q12h,持续48小时III级头孢曲松针1g IV qd,持续48小时克林霉素
听诊式胎儿监护仪临床应用研究

2020.04.17 听诊式胎儿监护仪临床应用研究

指标的描述将计算均值、标准差、中位数、最小值、最大值、下四分位数(Q1)、上四分位数(Q3),分类指标描述各类的例数及百分数。定量指标的组间比较根据数据分布情况...: 人民卫生出版社,2018:53-61.[5] 中华医学会围产医学分会. 电子胎心监护应用专家共识 [J]. 中华围产医学杂志,2015,(7
The Lancet最新综述:孤独症谱系障碍前沿与治疗

2018.08.14 The Lancet最新综述:孤独症谱系障碍前沿与治疗

(25-40%)、极端挑食(42-61%)、肥胖(23%)、胃肠道症状(47%)、消化系统问题(主要为排便问题和便秘)。在 ASD 患者中,癫痫的患病率为 8.6...特征已被单独研究,例如染色体 16p11.2 缺失或重复、母方 15q11- q13 重复。过去 15 年,已在超过 100 个基因中发现重复出现、新出现的
上一页 1 2 3 ... 48 49 50 下一页 到第